---
trial_id: 1438
discovery_date: 2022-07-13 16:41:46.229975
date: 2022-07-13 16:41:46.229975
title: "A Phase Ib Dose Finding Study Assessing Safety and Activity of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) in Combination With Carboplatin, Etoposide and Tislelizumab in Induction and With Tislelizumab in M ..."
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct05142696'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
